Similar articles

• Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.

  Simmons RL, Canafax DM, Strand M, Ascher NL, Payne WD, Sutherland DE, Najarian JS. Simmons RL, et al. Transplant Proc. 1985 Aug;17(4 Suppl 1):266-75. Transplant Proc. 1985. PMID: 3895665 Clinical Trial. No abstract available.
• Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.

  Sommer BG, Henry ML, Ferguson RM. Sommer BG, et al. Transplant Proc. 1986 Apr;18(2 Suppl 1):69-75. Transplant Proc. 1986. PMID: 3515698 No abstract available.
• Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?

  Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM. Posner MP, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1594-7. Transplant Proc. 1989. PMID: 2652519 Clinical Trial. No abstract available.
• [Lung transplantation].

  Date H, Shimizu N. Date H, et al. Nihon Rinsho. 2005 Apr;63 Suppl 4:678-84. Nihon Rinsho. 2005. PMID: 15861728 Review. Japanese. No abstract available.
• Steps in immunosuppression for renal transplantation.

  Starzl TE, Rosenthal JT, Hakala TR, Iwatsuki S, Shaw BW Jr, Klintmalm GB. Starzl TE, et al. Kidney Int Suppl. 1983 May;(14):S-60-5. Kidney Int Suppl. 1983. PMID: 6348374 Free PMC article. Review. No abstract available.